Back
  1. Home
  2. Profile of David Hull (ULiège)
Profil

Hull David

Département de droit

See author's contact details
Main Referenced Co-authors
Clancy, Michael J. (2)
Gordley, Catherine (1)
Main Referenced Keywords
EU competition law (9); Article 102 (3); drug pricing (3); patent settlements (3); AstraZeneca Judgement (1);
Main Referenced Disciplines
Economic & commercial law (20)
European & international law (20)

Publications (total 20)

The most downloaded
2506 downloads
Hull, D., & Gordley, C. (2018). Gun Jumping in Europe: An Overview of EU and National Case Law. e-Competitions. https://hdl.handle.net/2268/235450

The most cited

7 citations (Scopus®)

Hull, D. (February 2017). Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 3, 205-2018. doi:10.1093/jeclap/lpx004 https://hdl.handle.net/2268/235441

Hull, D. (2019). Droits européen et américain de la concurrence : hipsters contre bobo ? Revue de la Faculté de Droit de l'Université de Liège.
Peer reviewed

Hull, D. (04 December 2018). Biologics & Biosimilars [Paper presentation]. Competition Law Challenges.

Hull, D. (14 November 2018). Competition Law Strategies: - Protect Your Brand - - Protect Your Retail Partners - - Protect Your Revenue - [Paper presentation]. Luxury Law New York Summit.

Hull, D. (12 September 2018). Excessive Pricing in the Pharmaceutical Sector: Recent European Cases [Paper presentation]. European Pharma Law Academy.

Hull, D., & Clancy, M. J. (2018). The Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 389-402. doi:10.1093/jeclap/lpy035
Peer Reviewed verified by ORBi

Hull, D. (2018). Coty, Asics and Google Shopping: Practical Implications for Distribution Strategy.

Hull, D., & Gordley, C. (2018). Gun Jumping in Europe: An Overview of EU and National Case Law. e-Competitions.
Peer reviewed

Hull, D. (05 December 2017). Excessive Pricing in the Pharmaceuticals Sector [Paper presentation]. Competition Law in the Pharma Sector 2017.

Hull, D. (2017). The Intel Judgment:  Practical Implications for Pricing Strategies.

Hull, D. (13 September 2017). European Competition Law: Recent Developments in the Pharma Sector [Paper presentation]. European Pharma Law Academy.

Hull, D. (16 May 2017). Abuse of Dominance in the Pharmaceuticals Sector: Excessive Pricing, Rebates and Discounts [Paper presentation]. EU Pharmaceutical Law Forum 2017 Brussels.

Hull, D. (February 2017). Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 3, 205-2018. doi:10.1093/jeclap/lpx004
Peer Reviewed verified by ORBi

Hull, D. (06 December 2016). Patent Settlements under EU Competition Law [Paper presentation]. Competition Law in the Pharma Sector.

Hull, D. (24 May 2016). Abuse of Dominance in the Pharmaceuticals Sector [Paper presentation]. Informa’s 25th Annual EU Pharmaceutical Forum.

Hull, D. (2016). Lundbeck BSC Morning Briefing.

Hull, D., & Clancy, M. J. (2016). Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 7, 153-161. doi:10.1093/jeclap/lpv093
Peer Reviewed verified by ORBi

Hull, D. (2016). Patent settlements - The Knowledge Group.

Hull, D. (19 May 2015). Competition Cases on Product Denigration: What Can You Say About Competing Products? [Paper presentation]. EU Pharmaceutical Law Forum.

Hull, D. (2010). The AstraZeneca Judgment: Implications for IP and Regulatory Strategies. Journal of European Competition Law and Practice. doi:10.1093/jeclap/lpq057
Peer Reviewed verified by ORBi

Hull, D. (2006). Tying - A transatlantic Perspective. In P. Marsden (Ed.), Handbook of Research in Trans-Atlantic Antitrust (pp. 287-318). Edward Elgar.
Peer reviewed

Contact ORBi